H34.812
Central retinal vein occlusion, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Central retinal vein occlusion (CRVO) is a condition that affects the blood vessels in the eye, specifically blocking the central retinal vein. This blockage leads to significant changes in vision and can affect one or both eyes, depending on the severity and location of the occlusion. When it occurs in the left eye, it is classified under ICD-10 code H34.812. Recognizing the signs and understanding the underlying causes can help in seeking appropriate eye care and management.
Causes & Symptoms
Clinical Causes: Presence of blood clots in the central retinal vein High blood pressure (hypertension) Atherosclerosis (hardening of the arteries) Diabetes mellitus Glaucoma Blood disorders such as anemia or hypercoagulable states Inflammation or infection affecting the retinal vessels Eye trauma or injury Cardiovascular diseases Smoking and obesity, which contribute to vascular problems
Key Symptoms: Sudden loss of vision in the affected eye Blurred or distorted vision Presence of a dark or blind spot (scotoma) Reduced visual acuity Mild to severe swelling of the retina Possible appearance of blood and hemorrhages visible during eye examination Visual disturbances that may develop gradually or suddenly
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination, including dilated fundoscopy to observe the retina and blood vessels. Additional tests such as optical coherence tomography (OCT) help evaluate retinal swelling and fluid accumulation. Fluorescein angiography may be performed to assess blood flow and identify areas of blockage or leakage. A thorough medical history and physical examination are essential to identify underlying risk factors or associated systemic conditions that may contribute to CRVO.
Treatment Protocols: While specific treatments depend on the severity and progression of the condition, management aims to reduce complications and improve vision. Common approaches include: - **Injections of anti-vascular endothelial growth factor (anti-VEGF) agents** to reduce swelling and promote visual improvement - **Steroid injections or implants** to decrease inflammation - **Laser therapy** to treat abnormal blood vessels or areas of retinal ischemia - **Management of underlying health conditions** such as controlling blood pressure, blood sugar, and cholesterol levels - **Regular monitoring** to observe the progression and effectiveness of treatment Early detection and intervention are vital in preserving vision and preventing further complications.
Clinical Advice & FAQs
Billing Guidance
Is H34.812 a billable ICD-10 code?
Yes, H34.812 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H34.812?
Clinical documentation must specify the nature of Central retinal vein occlusion, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
